Texas Children's Cancer Center

Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.

The new Pediatric Center for Personal Cancer Genomics and Therapeutics plans to routinely sequence every new patient that comes into the Texas Children's Cancer Center and hopes eventually to begin sequencing all new pediatric cancer cases in the state of Texas.

BCM has started a new pediatric cancer research center that will use clinical tumor sequencing for research and to develop treatments.

The Doris Duke Charitable Foundation has given a nearly $500,000 grant to the Texas Children's Cancer Center and Baylor to identify glioma-causing genetic mutations.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.